Clinical trial
Evaluating ABX-EGF Extended Therapy in Subjects With MetastaticColorectal Cancer
NCT00113776 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00113776 |
|---|---|
| Title | Evaluating ABX-EGF Extended Therapy in Subjects With MetastaticColorectal Cancer |
| Official title | A Multicenter, Open-label, Single Arm Clinical Trial to Determine the Safety of ABX-EGF Extended Therapy in Subjects With Metastatic Colorectal Cancer |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | ABX-EGF |
| First posted | Jun 13, 2005 |
| Last update posted | Jan 21, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: